Europe's STOXX 600 eked out minor gains on Tuesday led by gains in industrials as investors assessed a slew of downbeat ...
AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a ...
AstraZeneca said on Tuesday that it does not comment on speculative media reports, in response to a sharp drop in its share ...
Britain's benchmark FTSE 100 edged lower on Tuesday, hurt by AstraZeneca's fall on a potential China probe, while investors ...
Over the past three years, additional insurance fraud cases have emerged involving AstraZeneca employees in various Chinese ...
Analyst Sachin Jain from Bank of America Securities maintained a Buy rating on AstraZeneca (AZN – Research Report) and keeping the price ...
AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...
The FTSE 100 finished 11.85 points, or 0.14%, lower to end the day at 8,172.39. In the US, Wall Street started trading in a ...
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on AstraZeneca (AZN – Research Report), with ...
AstraZeneca PLC, maintaining its operations in China, remains steadfast amidst speculative media scrutiny concerning ongoing ...